TAG:
cap
Non-Pathologists Altering U.S. Laboratory Industry
CEO SUMMARY: It’s an interesting contradiction. On one hand, most pathologists enthusiastically recognize the value that diagnostic testing services provide to the healthcare community. On the other hand, too often it is non-laboratorians who provide the investment capital and entrepren…
Changes Expected in Market For Hospital Reference Testing
CEO SUMMARY: For the hospital send-out testing marketplace, 2002 has been an eventful year. First came the acquisition of American Medical Laboratories by Quest Diagnostics Incorporated. In April, Specialty Laboratories disclosed its problems with state and federal laboratory regulators. …
Read “Waiver of Charges” for What It Is: FREE!
TODAY I AM AN OLD CURMUDGEON WHO IS IN HIGH DUDGEON. What’s got my dander up is the disturbing revelation in this issue of THE DARK REPORT about the willingness by some of our industry’s biggest companies to use “free testing” as a way to protect and build market share. (See pages 2-8…
Two Blood Brothers Use “Free Testing” Strategy
CEO SUMMARY: It’s a business strategy that Quest Diagnostics Incorporated and Laboratory Corporation of America use in selected areas where they have lost exclusive managed care contracts to regional lab competitors. In order to retain access to a physician’s fee-for-service testing b…
Will “Free Testing” Ploy Financially Affect Labs?
CEO SUMMARY: It’s a marketing scheme which public lab companies have quietly used for years. Now there is evidence that the use of “Waiver of Charges to Managed Care Patients” (free testing) seems to be on the increase, raising new questions about how and why competitive practices a…
Lab Competitors Pool Lab Data For Clinicians In British Columbia
CEO SUMMARY: In British Columbia, two commercial laboratory competitors have found common ground. BC Biomedical Laboratories and MDS Metro Laboratories are using LOINC to link their laboratory test databases. Physicians use a single system to access their patient’s test results, regardl…
Quest Diagnostics, CVS Pharmacies, Premier, Novation, Luminex, Careside.
QUEST DOES DEAL WITH CVS DRUGSTORES FOR LAB TESTING PATHOLOGISTS CONCERNED about pharmacists moving into the lab testing arena should closely watch the newly-announced relationship between Quest Diagnostics Incorporated and CVS Corporation. Starting this m…
Dade Behring Primed To Become Public Firm
CEO SUMMARY: Dade Behring is executing an ambitious plan to restructure its finances and become a public company. To reduce its debt burden, Dade’s three owners are giving up their stock. Banks and bondholders will swap a portion of their debt for shares of stock in Dade. Once the finan…
Specialty Laboratories’ New CEO Reveals How His Company Is Changing
“You will see a more tightly focused Specialty Labs. We won’t try and do everything, rather we will do what is important for our customers.” —Douglas S. Harrington, M.D CEO SUMMARY: In recent months, several events roiled the market for hos…
Specialty Progresses With CA Lab Regulators
CEO SUMMARY: Earlier this month California laboratory regulators found Specialty Laboratories, Inc. to be “in substantial compliance with California clinical laboratory law.” This is an important milestone in restoring the lab company to full compliance with both state and federal labor…
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.